FF-10101 is a novel irreversible FLT3 inhibitor with ic50 of 0.20 nM and 0.16 nM for FLT3 (WT) and FLT3(D835Y), respectively.
此产品仅用于科学研究,我们不为任何个人用途提供产品和服务
FF-10101 is a novel irreversible FLT3 inhibitor with ic50 of 0.20 nM and 0.16 nM for FLT3 (WT) and FLT3(D835Y), respectively.
FF-10101 potently and selectively inhibits the growth of mutant FLT3-expressing leukemia cells in vitro.[1]
Oral administration of FF-10101 shows significant anti-leukemic effects at 5 mg/kg and 10 mg/kg twice daily for 11 days in the PDX model of AML cells with FLT3-ITD.[1]
[1] Yamaura T,et al.Blood. 2018 25;131(4):426-438.
没有评价数据